Showing 96 of 96on this page. Filters & sort apply to loaded results; URL updates for sharing.96 of 96 on this page
Repotrectinib Chemical Formula Molecular Structure Repotrectinib Stock ...
Fig. 1: Repotrectinib chemical structure
Repotrectinib Molecular Structure 3d Flat Model Stock Illustration ...
RCSB PDB - 7VKO: Crystal structure of TrkA kinase with repotrectinib
Repotrectinib | C18H18FN5O2 | CID 135565923 - PubChem
Repotrectinib (TPX-0005) | ROS1/TRK/ALK Inhibitor | MedChemExpress
Repotrectinib (TPX-0005) | ALK阻害剤 | 被引用10超え | 国内在庫 | Selleck ジャパン
Repotrectinib | 1802220-02-5 | CXC22002 | Biosynth
Repotrectinib | CAS NO.:1802220-02-5 | GlpBio
Repotrectinib | 化合物TPX0005 | TargetMol
repotrectinib
DailyMed - AUGTYRO- repotrectinib capsule
Repotrectinib Cancer Drug Molecule Skeletal Formula Stock Vector ...
Crystal structure of repotrectinib, C18H18FN5O2 | Powder Diffraction ...
Repotrectinib – Xcess Biosciences
Repotrectinib | CAS#:1802220-02-5 | Chemsrc
Repotrectinib | 1802220-02-5 | Reference standards | Shimadzu Chemistry ...
Repotrectinib - Drugs and Lactation Database (LactMed®) - NCBI Bookshelf
Repotrectinib (瑞普替尼) – 美仑生物
Repotrectinib | 1802220-02-5 | In stock | Aktin Chemicals,Inc
repotrectinib | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Repotrectinib | 1802220-02-5
Repotrectinib | The Merck Index Online
Repotrectinib Impurity-8 1802221-21-1
RCSB PDB - 7VKN: Crystal structure of TrkA (G595R) kinase with ...
Repotrectinib Impurity-10 1802220-02-5
化合物TPX0005 Repotrectinib CAS : 1802220-02-5 - 生命科学产品与技术服务-生工生物工程(上海)股份有限公司
Repotrectinib Impurity-9 1802222-30-5
Repotrectinib - API Standards | CAS No: 1802220-02-5
Figure 3 from Molecular Characteristics of Repotrectinib That Enable ...
Repotrectinib Impurity-3 926663-00-5
Repotrectinib (Augtyro) 2025 Updates: Uses in Cancer, Side effects ...
Figure 1 from Molecular Characteristics of Repotrectinib That Enable ...
Scheme 8. Synthesis of repotrectinib ( 8 ).
Repotrectinib | Trk receptor | ROS | Src | ALK | ROS Kinase | TargetMol
Repotrectinib Impurity-5 1802222-53-2; 1228570-33-9
Structure of macrocyclic peptides synthesized by Coppock et al. (2019 ...
Larotrectinib Molecule Flat Skeletal Structure Tyrosine Stock Vector ...
Thuốc Repotrectinib điều trị ung thư phổi tế bào nhỏ dương tính ROS1
Repotrectinib Impurity-7 1802222-29-2
Repotrectinib Impurity-1 6994-25-8;1260243-04-6
Repotrectinib Impurity-6 119768-44-4
选择性 II 型 TRK 抑制剂克服 xDFG 突变介导的对第二代抑制剂 selitrectinib 和 repotrectinib 的获得性 ...
Augtyro (Repotrectinib Capsules): Side Effects, Uses, Dosage ...
CAS 1802220-02-5 (Repotrectinib) - BOC Sciences
Repotrectinib(TPX-005)|ALK/ROS1/TRK inhibitor
ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition ...
瑞普替尼repotrectinib-药品详情-NextPharma®数据库-ByDrug-医药魔方数据库
Repotrectinib, 1802220-02-5 | BroadPharm
151 Tropomyosin Royalty-Free Images, Stock Photos & Pictures | Shutterstock
Targeted Therapies in Cancer: To Be or Not to Be, Selective
新一代超强广谱抗癌药瑞波替尼（TPX-0005、Repotrectinib）说明书-上市-用法用量-价格-临床试验招募 - 知乎
PharmDev360: REVIEW: AUGTYRO (Repotrectinib Capsule)
Pyrazole-containing pharmaceuticals: target, pharmacological activity ...
2023年获FDA批准的小分子新药及药物设计思路 - 知乎
肺癌多靶点新药洛普替尼中国数据最新出炉-印塔健康官网
占据五分之一！2023年FDA批准的含氟新药全盘点 - 知乎
Chemical structures of larotrectinib and entrectinib. | Download ...
日本医薬品一般的名称（JAN）データベース
Green Synthesis of Repotrectinib: Impact of Aqueous Micellar Media on ...
The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals ...
FDA‐approved drugs featuring macrocycles or medium‐sized rings - PMC
EU 2025 « New Drug Approvals
Larotrectinib cancer drug molecule. Skeletal formula Stock Vector Image ...
Larotrectinib cancer drug molecule, illustration Stock Photo - Alamy
TianYuan Pharmaceutical Co.,Limited
Repotrectinib,TPX-0005,1802220-02-5,上海麦克林生化科技股份有限公司 – 960化工网
2D chemical structures of RET inhibitors 1−5 and the recently ...
Turning Point – New Drug Approvals
Repotrectinib/TPX-0005 - Jinan Million Pharmaceutical Co., Ltd
祝贺！百时美施贵宝repotrectinib获FDA批准 百时美施贵宝 （Bristol Myers Squibb）宣布，美国FDA批准其口服 ...
Exploring Macrocyclic Chemical Space: Strategies and Technologies for ...
Repotrectinib|Augtyro®|86|2025 | PZ – Pharmazeutische Zeitung
第2代ROS1/NTRK抑制剂Repotrectinib（Augtyro、瑞普替尼、瑞波替尼）获FDA批准上市 - 知乎
Larotrectinib cancer drug molecule. Skeletal formula Stock Photo - Alamy
Larotrectinib Cancer Drug Molecule Skeletal Formula Stock Vector ...
Lack of Contribution of Multidrug Resistance-associated Protein and ...
